FACULTY
Toby Maher, MD, MSc, PhD, FRCP
Professor of Clinical Medicine
Director of Interstitial Lung Disease
Keck School of Medicine
University of Southern California
Los Angeles, California
PROGRAM OVERVIEW
This virtual preceptorship provides a broad-based approach to the diagnosis and targeted treatment of fibrosing interstitial lung diseases (F-ILD), including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Expert faculty guide learners through the spectrum of clinical characteristics and histopathologic patterns of F-ILD and demonstrate how pattern recognition at the bedside and on HRCT can accelerate appropriate referral and reduce diagnostic delay.
Through a longitudinal patient case, learners will apply structured diagnostic workflows encompassing pulmonary function testing, autoimmune serologies, multidisciplinary team discussion, and guideline criteria to arrive at an accurate diagnosis and individualized treatment plan. The program evaluates current and emerging antifibrotic therapy trial data and addresses shared decision-making and quality-of-life interventions to support comprehensive, patient-centered care across the F-ILD disease trajectory.
TARGET AUDIENCE
This activity is designed to meet the educational needs of pulmonologists as well as related NPs and PAs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe clinical characteristics for F-ILD/PPF
- Collaborate with a multidisciplinary team for a complete diagnostic workup for F-ILD/PPF
- Evaluate clinical data for current and emerging therapies and effective treatment strategies for patients with F-ILD/PPF
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in this enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this enduring activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Toby Maher, MD, MSc, PhD, FRCP | Consulting Fees: AbbVie, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Chiesi, GSK, Insmed, Merck & Co., Pfizer, PureTech, Redx, UCB, and United Therapeutics. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Shannon Mutch MS, RN, OCN, has nothing to disclose.
- La Donna Lue Winston, MSN, APRN, AGACNP-BC, SCRN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Sharon Windsor Harker, BSc, Medical Director for Med Learning Group, has nothing to disclose.
- Russie Allen, MS, Accreditation & Outcomes Manager for Med Learning Group, has nothing to disclose.
- Felecia Beachum, Sr. Program Manager for Med Learning Group, has nothing to disclose.
- Melanie Grau, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: June 16, 2026
EXPIRATION DATE: June 16, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
